Objectives: Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. T
Excision of axillary lymph node recurrences in breast cancer patients with axillary ROLL (A-ROLL)
✍ Scribed by Fatİh Aydogan; Volkan Ozben; Denİz Atasoy; Mehmet Halİt Yilmaz; Metİn Halaç; Varol Çelİk
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 115 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objectives
Conventional surgical exploration to find clinically occult axillary lymph node recurrence of breast cancer can be challenging. The aim of this study was to determine the place of our alternative technique, axillary‐ROLL (A‐ROLL), in previously treated breast cancer patients with nonpalpable axillary lymph node recurrences.
Methods
Between March 2005 and May 2009, included in this retrospective study were four women (age, 42–51 years) without clinical evidence of distant metastasis who had treatment for breast cancer and were subsequently found to have suspicious axillary lymph node(s) detected by control ultrasonography (US) examination during follow‐up. A‐ROLL was utilized for the identification of lymph nodes. 0.5–1 mCi ^99m^Tc‐human serum albumin makroaggregate was injected under US guidance. A gamma probe was then used to guide the excision of the lymph nodes.
Results
The involved lymph nodes were successfully localized by A‐ROLL technique and removed surgically. Of all four patients, postoperative histopathologic examination revealed nodal cancer metastases in three patients (75%) and lymphoid hyperplasia in one patient. No complications occurred.
Conclusions
A‐ROLL technique has proved to be accurate and safe in the identification and excision of clinically occult axillary lymph node recurrence. J. Surg. Oncol. 2010;101:141–144. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Adjuvant therapy for women with T1–T2 breast carcinoma and 1–3 positive lymph nodes is controversial due to discrepancies in reported baseline locoregional recurrence (LRR) risks. This inconsistency has been attributed to variations in lymph node staging techniques, which
Abstract This work has identified variables of importance to short- and long-term prognosis in 97 node positive breast cancer patients followed for a minimum of 98 months. The diameter of the primary tumour (⩽3 cm/>3 cm) is shown to be an important prognostic variable. Its addition to the presence/a